eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Documenthome » Food and Drug Administration Actions Related to Nicotine Replacement Therapies and Smoking-Cessation Products; Report to Congress on Innovative Products and Treatments for Tobacco Dependence; Public Hearing; Extension of Comment Period

Food and Drug Administration Actions Related to Nicotine Replacement Therapies and Smoking-Cessation Products; Report to Congress on Innovative Products and Treatments for Tobacco Dependence; Public Hearing; Extension of Comment Period

Document ID: FDA-2012-N-1148-0011

Comments

Total: 50
Christine Kuppler - Comment
Posted : 03/13/2013     ID ：FDA-2012-N-1148-0063     Agency : FDA

Jan 16,2013 11:59 PM ET
Russell Andrew Hauss - Comment
Posted : 03/13/2013     ID ：FDA-2012-N-1148-0064     Agency : FDA

Jan 16,2013 11:59 PM ET
April D Thompson - Comment
Posted : 03/13/2013     ID ：FDA-2012-N-1148-0065     Agency : FDA

Jan 16,2013 11:59 PM ET
leonard gary warren - Comment
Posted : 03/13/2013     ID ：FDA-2012-N-1148-0066     Agency : FDA

Jan 16,2013 11:59 PM ET
Judy Lombard-Newell - Comment
Posted : 03/13/2013     ID ：FDA-2012-N-1148-0067     Agency : FDA

Jan 16,2013 11:59 PM ET
Ryan Joseph Kelly - Comment
Posted : 03/13/2013     ID ：FDA-2012-N-1148-0068     Agency : FDA

Jan 16,2013 11:59 PM ET
Chris Michael Davis - Comment
Posted : 03/13/2013     ID ：FDA-2012-N-1148-0069     Agency : FDA

Jan 16,2013 11:59 PM ET
Alok Desai - Comment
Posted : 03/13/2013     ID ：FDA-2012-N-1148-0070     Agency : FDA

Jan 16,2013 11:59 PM ET
Maher Karam-Hage - Comment
Posted : 03/13/2013     ID ：FDA-2012-N-1148-0071     Agency : FDA

Jan 16,2013 11:59 PM ET
michelle lynn jude - Comment
Posted : 03/13/2013     ID ：FDA-2012-N-1148-0072     Agency : FDA

Jan 16,2013 11:59 PM ET
Scott D. Ballin, JD - Comment
Posted : 04/01/2013     ID ：FDA-2012-N-1148-0073     Agency : FDA

Jan 16,2013 11:59 PM ET
Ken P. Wassum (Alere Wellbeing) - Comment
Posted : 04/01/2013     ID ：FDA-2012-N-1148-0074     Agency : FDA

Jan 16,2013 11:59 PM ET
Andrew Taylor (CASAA) - Comment
Posted : 04/01/2013     ID ：FDA-2012-N-1148-0075     Agency : FDA

Jan 16,2013 11:59 PM ET
Brian M. French (CASAA) - Comment
Posted : 04/01/2013     ID ：FDA-2012-N-1148-0076     Agency : FDA

Jan 16,2013 11:59 PM ET
Debbie Nogueras - Comment
Posted : 04/12/2013     ID ：FDA-2012-N-1148-0077     Agency : FDA

Jan 16,2013 11:59 PM ET
Ausstin White - Comment
Posted : 04/12/2013     ID ：FDA-2012-N-1148-0078     Agency : FDA

Jan 16,2013 11:59 PM ET
Douglas Halliwell Cornish - Comment
Posted : 04/12/2013     ID ：FDA-2012-N-1148-0079     Agency : FDA

Jan 16,2013 11:59 PM ET
Jacob A. Wiesehan - Comment
Posted : 04/12/2013     ID ：FDA-2012-N-1148-0080     Agency : FDA

Jan 16,2013 11:59 PM ET
Donald John Muehlbauer - Comment
Posted : 04/12/2013     ID ：FDA-2012-N-1148-0081     Agency : FDA

Jan 16,2013 11:59 PM ET
Angela Lynn Tourtellot - Comment
Posted : 04/12/2013     ID ：FDA-2012-N-1148-0082     Agency : FDA

Jan 16,2013 11:59 PM ET